title: Beneficial and adverse effects of correction of anaemia by recombinant human erythropoietin in patients on maintenance haemodialysis.
authors.affiliation: Department of Nephrology, University Hospital of Frankfurt/M., FRG.
authors.forename: P
authors.initials: P
authors.lastname: Grützmacher
authors.forename: M
authors.initials: M
authors.lastname: Bergmann
authors.forename: T
authors.initials: T
authors.lastname: Weinreich
authors.forename: U
authors.initials: U
authors.lastname: Nattermann
authors.forename: E
authors.initials: E
authors.lastname: Reimers
authors.forename: M
authors.initials: M
authors.lastname: Pollok
mesh_terms: D000740:Anemia / Q000209:etiology / Q000628:therapy*; D002986:Clinical Trials as Topic; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D010809:Physical Fitness; D011897:Random Allocation; D011994:Recombinant Proteins / Q000627:therapeutic use*; D006435:Renal Dialysis
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin